|3 Months Ended|
Mar. 31, 2023
|Stockholders' Equity Note [Abstract]|
NOTE 6 – STOCKHOLDERS’ EQUITY
The Company had 26,126,740 and 26,043,406 shares of its Common Stock issued and outstanding at March 31, 2023 and 2022, respectively.
Common Stock Issuances for the Three Months Ended March 31, 2023
During the three months ended March 31, 2023, the Company issued 83,334 shares of common stock due to the vesting of restricted stock units, and recognized approximately $24,000 of stock-based compensation expense related to its outstanding restricted stock units. Stock-based compensation expense related to the Company’s restricted stock units is recognized within selling, general and administrative expense. As of March 31, 2023, remaining unamortized RSU stock-based compensation expense was approximately $165,500.
The Company did not grant any restricted stock units or restricted stock during the three months ended March 31, 2023.
No definition available.
The entire disclosure for equity.
Reference 1: http://www.xbrl.org/2003/role/disclosureRef